Bring your vision of better patient health to life by partnering with Algok Bio
We leverage our team’s years of successful drug development experience to in-license or acquire promising leads and mature them into acquisition-ready or commercialized assets.
About
Algok Bio
Our relentless approach to finding and advancing the most promising therapeutic programs and precision medicine approaches is bringing our vision of a healthier tomorrow to life.
“Around the world small startups and academic labs are hard at work turning their specialized insights into future patient treatments. But only ~4% of these attempts will mature into an approved therapeutic.”
At Algok Bio, we know what a successful lead looks like. That's why we in-license or acquire the most promising candidates for development and commercialization.
Our name reflects this approach. In Korean Algok means “grain”. Like the farmer who separates the inedible chaff from the nourishing wheat within, we sift through the many drug discovery projects to find the most promising candidates and get them ready for market.
Visit our pipeline page to see what leads we have in development, including exciting precision medicine-enabling molecules, and learn more about our experienced team on the About page.
Our Approach
We look for those rare preclinical programs that we know will succeed, take them through preclinical and clinical development, and out-license during late clinical development or after commercialization.
